DRAK2, active
10 µg of active DRAK2. N-terminal 6His-tagged, recombinant, full length, human DRAK2.
Biological information
Background
DRAK2, also known as Serine/Threonine Kinase 17b, enables ATP binding activity and protein serine/threonine kinase activity. It involves in intracellular signal transduction and positive regulation of fibroblast apoptotic process. [provided by Alliance of Genome Resources, Apr 2022]
Target class
Kinase
Family
CAMK
Accession number
NM_004226.4
Target Name
DRAK2, active
Target Alias
STK17B; Serine/Threonine Kinase 17b; Death-Associated Protein Kinase-Related 2; Serine/Threonine Kinase 17b (Apoptosis-Inducing)
Origin
Human
Theori. MW
46 kDa
Affinity tag
6His
Product specifications
Expression system
Expressed by baculovirus in Sf21 insect cells
Purity
81% by SDS-PAGE and Coomassie blue staining.
Purification method
Immobilised metal affinity chromatography
Sample Buffer
1.28 mg/ml of enzyme in 50 mM Tris/HCl pH 7.5, 300 mM NaCl, 0.1 mM EGTA, 0.03% Brij-35, 270 mM sucrose, 1 mM benzamidine, 0.2 mM PMSF, 0.1% 2-mercaptoethanol. Frozen solution.
Specified activity
Refer to CoA
Application
For Research Only
Storage conditions
1 year at -70°C.
Usage disclaimer
For Research Only
Chemical data
Background
DRAK2, also known as Serine/Threonine Kinase 17b, enables ATP binding activity and protein serine/threonine kinase activity. It involves in intracellular signal transduction and positive regulation of fibroblast apoptotic process. [provided by Alliance of Genome Resources, Apr 2022]
Compound name
Kinase
Catalog number
16-003
Molecular formula
CAS
MW
Ka
Percent composition
Product specifications
Physical state
Purity (HPLC 214nm)
Retention time (RP18 HPLC)
CMC
Exact mass
Stability
For Research Only
Solubility structure
Datasheets
16-003
Datasheet